News & Events - TVM Capital Life Science Venture Capital

Skip to main content

Get the latest information on TVM and its portfolio companies.

We hope to see you at an upcoming event.

Get the latest information on TVM and its portfolio companies.

Events

November 3–5, 2025

BIO-Europe 2025

TVM Capital Life Science will take part in BIO-Europe November 3–5, 2025 in Vienna, Austria.

Vienna, Austria

Website

November 6, 2025

Handelsblatt Konferenz Biotech

From Science to Market: Business, Regulation & Investment

Berlin, Germany

Website

News

October 21, 2025

FDA Clears Access Vascular HydroMid® and HydroPICC® Catheters With Anti-Thrombogenic Indication

October 16, 2025

TVM Capital Life Science Portfolio Company Smart Reporting to Acquire Fluency for Imaging – Uniting to Create Jacobian™ and Accelerate AI-Powered Reporting

October 7, 2025

Vektor Medical Secures CE Mark for vMap, Bringing the Benefits of Non-Invasive Arrhythmia Mapping to Europe

September 22, 2025

Kent Imaging’s SnapshotNIR Receives CE Marking: Advances Clinical Adoption in the European Union & United Kingdom

September 4, 2025

AL-S Pharma Announces Positive Topline Results from Phase 2 Study of AP-101 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

August 13, 2025

New Study Demonstrates Superiority of EggNest™ Complete Radiation Protection System in Comprehensive Protection for the Entire Interventional Team

First Patients Enrolled in IMPRoVED-AF Study Using vMap, a Non-Invasive ECG-Based Tool Designed to Guide More Effective AF Ablation

Real-World Evidence Study Uses SnapshotNIR on 4,000+ Wounds to Deliver Targeted Care and Improve Healing Outcomes

Cellestia Biotech and TVM Capital Life Science Announce Creation of Anciata Therapeutics to Develop a First-in-Class Therapeutic Targeting Autoimmune Disorders

Study at CRT 2025 Demonstrates Superiority of EggNest™ Complete Radiation Protection System Compared to Rampart Defender System in Total Room Protection

February 20, 2025

Amann Girrbach North America and Panthera Dental Join Forces to Simplify Workflows for Implant Bar and Bridge Restorations.

February 19, 2025

BIOTRONIK and Egg Medical Form Strategic Alliance to Improve Radiation Protection for Interventional Healthcare Workers

November 22, 2024

Kent Imaging Recognized for Its Pioneering Spirit by Start Alberta’s 2024 Annual Awards

October 30, 2024

Discover the Power of AI in Biopharma: TVM to Host Thought-Provoking Sessions at Bio-Europe 2024

October 8, 2024

Data Presented at the American College of Chest Physicians Correlates Airway Remodeling with Positive Clinical Outcomes Utilizing the RejuvenAir® System

September 11, 2024

TVM Capital Life Science to Participate in LSI Europe ’24 Emerging Medtech Summit 2024

September 9, 2024

CSA Medical Raises $53 Million in Series D Financing to Support PMA of the RejuvenAir System

September 4, 2024

Access Vascular Announces Strategic Partnership with Capstone Health Alliance

Leon-Nanodrugs Secures Funds in a Series D Financing

Access Vascular Prepares Catheter Location Technology for FDA Submission

Kent Imaging Announces FDA Clearance of SnapshotNIR KD205

TVM Capital Life Science Leads €23 Million Series C Financing Round for Medical Reporting Technology Pioneer, Smart Reporting

Kent Imaging and WoundCentrics Propel Wound Care Forward with New Partnership

TVM Capital Life Science to Participate in LSI USA ’24 Emerging MedTech Summit 2024

February 6, 2024

TVM Capital Life Science Co-Leads $16 Million Series A Financing Round for Vektor Medical to Revolutionize Arrhythmia Care

January 31, 2024

TVM Capital Life Science Announces €8 Million Investment in myo to Revolutionize Elderly Care via Innovative, Easy-to-Use App

Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis

TVM Capital Life Science to participate in LSI USA ’23 Emerging Medtech Summit 2023

February 23, 2023

TVM Capital Life Science Announces Promotions to Recognize Significant Contributions of Up-and-Coming Leaders

February 21, 2023

Esperas Pharma, Inc. Announces Investment from TVM Life Science Innovation I and The Fonds de solidarité FTQ

February 1, 2023

TVM Capital Life Science announces up to USD 24 million investment in oncology company, Recurv Pharma, Inc.

Panthera D-SAD Classic oral appliance now eligible for Medicare reimbursement

Kent Imaging Recognized as Most Innovative Medical Imaging Technology Developer in Canada

Egg Medical, Inc., Closes on $13 million Financing

February 8, 2022

CENTOGENE Announces CFO Transition and Appointment of Miguel Coego Rios as EVP Finance & Legal and Interim CFO

February 1, 2022

CENTOGENE Announces Nomination of Andreas Busch to Supervisory Board

February 1, 2022

CENTOGENE Announces USD 62 Million Aggregate Equity and Debt Financings to Support Growth Plan

February 1, 2022

CENTOGENE Announces Nomination of Kim Stratton as Chief Executive Officer

January 13, 2022

Syndivia and TVM Capital Life Science Announce Creation of Auricula Biosciences to Develop Innovative Therapy for Patients with K-Ras mutant malignancies

January 12, 2022

TVM Capital Life Science promotes Dr. Sascha Berger and Dr. Alain Thibault to General Partner

November 19, 2021

Acer Therapeutics Reports Q3 2021 Financial Results and Provides Corporate Update

November 15, 2021

Nekonal and TVM Capital Life Science Announce Creation of T7 Therapeutics to Develop Innovative Therapy for Patients with Auto-immune diseases

October 7, 2021

Acer Therapeutics Receives Notice of Allowance of Key U.S. Patent Application Covering ACER-001 Formulation

October 6, 2021

CENTOGENE and Twist Bioscience to Develop Advanced Sequencing Tools to Make Genetic Testing Rapidly Accessible for More Patients With Rare Diseases

Rapid Micro Biosystems Announces Pricing of Initial Public Offering

Acer Therapeutics Plans NDA Submission for ACER-001 in Q3 2021
Following Pre-NDA Meeting with FDA

Relief and Acer Therapeutics Sign Collaboration and License Agreement for Worldwide Development and Commercialization of ACER-001 for the Treatment of Urea Cycle Disorders and Maple Syrup Urine Disease

Access Vascular, Inc. Secures $20 Million in Series B Financing

February 1, 2021

TVM Life Science Innovation II SCSp Announces Investment in Vespina Lifesciences Inc.

February 1, 2021

TVM Life Science Innovation II SCSp Announces Investment in Sarkana Pharma, Inc.

January 25, 2021

Kent Imaging Becomes Net Health’s First Integrated Imaging Device

January 19, 2021

TVM Life Science Innovation II SCSp Announces Investment in ImmunoRx Pharma, Inc.

January 13, 2021

Kent Imaging Inc. is accelerating its growth through a US$15M investment by TVM Life Science Innovation II SCSp

November 13, 2020

Dentsply Sirona and Panthera Dental announce collaboration: fully digital workflow for custom-made sleep devices

October 27, 2020

TVM Capital Life Science Announces Substantially Oversubscribed US$478 Million Final Closing of TVM Life Science Innovation II, largest fund in the firm’s history